"Mycosis Fungoides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
Descriptor ID |
D009182
|
MeSH Number(s) |
C04.557.386.480.750.800.550 C15.604.515.569.480.750.800.550 C20.683.515.761.480.750.800.550
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycosis Fungoides".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, T-Cell [C04.557.386.480.750]
- Lymphoma, T-Cell, Cutaneous [C04.557.386.480.750.800]
- Mycosis Fungoides [C04.557.386.480.750.800.550]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, T-Cell [C15.604.515.569.480.750]
- Lymphoma, T-Cell, Cutaneous [C15.604.515.569.480.750.800]
- Mycosis Fungoides [C15.604.515.569.480.750.800.550]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
- Mycosis Fungoides [C20.683.515.761.480.750.800.550]
Below are MeSH descriptors whose meaning is more specific than "Mycosis Fungoides".
This graph shows the total number of publications written about "Mycosis Fungoides" by people in this website by year, and whether "Mycosis Fungoides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 2 | 6 |
1995 | 2 | 0 | 2 |
1996 | 2 | 2 | 4 |
1997 | 1 | 1 | 2 |
1998 | 4 | 0 | 4 |
1999 | 3 | 1 | 4 |
2000 | 1 | 2 | 3 |
2001 | 7 | 0 | 7 |
2002 | 9 | 0 | 9 |
2003 | 10 | 1 | 11 |
2004 | 3 | 0 | 3 |
2005 | 1 | 0 | 1 |
2006 | 7 | 1 | 8 |
2007 | 4 | 3 | 7 |
2008 | 8 | 2 | 10 |
2009 | 5 | 0 | 5 |
2010 | 5 | 1 | 6 |
2011 | 5 | 2 | 7 |
2012 | 10 | 1 | 11 |
2013 | 5 | 0 | 5 |
2014 | 8 | 1 | 9 |
2015 | 8 | 3 | 11 |
2016 | 5 | 0 | 5 |
2017 | 10 | 0 | 10 |
2018 | 6 | 1 | 7 |
2019 | 5 | 0 | 5 |
2020 | 5 | 0 | 5 |
2021 | 5 | 0 | 5 |
2022 | 7 | 0 | 7 |
2023 | 5 | 0 | 5 |
2024 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycosis Fungoides" by people in Profiles.
-
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and S?zary Syndrome. Transplant Cell Ther. 2024 Nov; 30(11):1047-1060.
-
Approach to Mycosis Fungoides in children: Consensus-based recommendations. J Am Acad Dermatol. 2024 Dec; 91(6):1078-1085.
-
On the Way to Curing Advanced-Stage Mycosis Fungoides/S?zary Syndrome. Clin Lymphoma Myeloma Leuk. 2024 Dec; 24(12):827-836.
-
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells. 2024 Feb 27; 13(5).
-
Phenotypic switch in mycosis fungoides: A tertiary cancer center experience. Hum Pathol. 2023 12; 142:27-33.
-
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States. Clin Lymphoma Myeloma Leuk. 2024 02; 24(2):e21-e32.e4.
-
Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. J Cutan Pathol. 2023 Aug; 50(8):711-716.
-
Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment. J Am Acad Dermatol. 2023 06; 88(6):e305-e306.
-
Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA). Best Pract Res Clin Haematol. 2023 03; 36(1):101448.
-
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.